Shukra Pharmaceuticals Limited (BOM:524632)
India
· Delayed Price · Currency is INR 40.78
-0.65 (-1.57%)
At close: Mar 9, 2026
Shukra Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 95.75 | 185.37 | 44.07 | 7.51 | 1.88 | Upgrade
|
| Depreciation & Amortization | - | 30.05 | 20.5 | 18.38 | 16.62 | 14.74 | Upgrade
|
| Other Operating Activities | - | -8.85 | 2.21 | -4.5 | 0.8 | -1.24 | Upgrade
|
| Change in Accounts Receivable | - | 157.46 | 56.74 | -227.86 | 23.47 | -9.52 | Upgrade
|
| Change in Inventory | - | -76.39 | 8.42 | 7.97 | -22.72 | -2.95 | Upgrade
|
| Change in Accounts Payable | - | 19.95 | -261.51 | 260.97 | 32.61 | -9.52 | Upgrade
|
| Change in Other Net Operating Assets | - | -138.79 | -63.7 | -67.33 | 21.6 | 11.98 | Upgrade
|
| Operating Cash Flow | - | 79.18 | -51.97 | 31.7 | 79.89 | 5.37 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -60.32% | 1386.79% | -54.90% | Upgrade
|
| Capital Expenditures | - | -27.43 | -17.6 | -44.91 | -15.5 | -17.91 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.05 | Upgrade
|
| Investment in Securities | - | - | - | - | -0.09 | -1.43 | Upgrade
|
| Other Investing Activities | - | 14.79 | 5.59 | 0.64 | 0.31 | 0.34 | Upgrade
|
| Investing Cash Flow | - | -12.64 | -12.01 | -44.27 | -15.28 | -18.95 | Upgrade
|
| Long-Term Debt Issued | - | 4.56 | - | 6.42 | - | 17.36 | Upgrade
|
| Long-Term Debt Repaid | - | - | -11.12 | - | -63.94 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 4.56 | -11.12 | 6.42 | -63.94 | 17.36 | Upgrade
|
| Issuance of Common Stock | - | - | 138.72 | 46.28 | - | - | Upgrade
|
| Common Dividends Paid | - | -43.79 | -0.7 | -0.73 | - | - | Upgrade
|
| Other Financing Activities | - | -5.95 | -2.85 | -2.56 | -2.81 | - | Upgrade
|
| Financing Cash Flow | - | -45.18 | 124.05 | 49.41 | -66.75 | 17.36 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | - | 21.37 | 60.08 | 36.84 | -2.15 | 3.78 | Upgrade
|
| Free Cash Flow | - | 51.75 | -69.57 | -13.22 | 64.39 | -12.54 | Upgrade
|
| Free Cash Flow Margin | - | 15.88% | -9.33% | -2.22% | 31.43% | -11.20% | Upgrade
|
| Free Cash Flow Per Share | - | 0.12 | -0.16 | -0.20 | 1.03 | -0.20 | Upgrade
|
| Cash Interest Paid | - | 5.95 | 2.85 | 2.56 | 2.81 | 0.13 | Upgrade
|
| Cash Income Tax Paid | - | 37.62 | 6.25 | 2.5 | 4.37 | - | Upgrade
|
| Levered Free Cash Flow | - | 32.25 | -123.17 | -43.52 | 57.98 | -13.32 | Upgrade
|
| Unlevered Free Cash Flow | - | 35.51 | -121.45 | -41.92 | 59.74 | -13.24 | Upgrade
|
| Change in Working Capital | - | -37.77 | -260.05 | -26.24 | 54.96 | -10 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.